Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT03286335
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Proton Radiation — RADIATIONRadiation treatment
Study Details
This research study is studying Proton Radiation as a possible treatment for brain tumor. The radiation involved in this study is: -Proton Radiation
Key Dates
- Start date
- Sep 26, 2018
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Proton Radiation* Radiation therapy will be delivered typically five (5) days per week on weekdays * Proton Radiation dose be determine by histology
Primary Outcome Measure
Duration of Local Control [ Time Frame: 2 years ]
Central Contacts
- Tarin Grillo617-724-3661
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02214 | Helen A Shih, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Related Studies
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain MetastasesRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)Recruiting · GT Medical Technologies, Inc. · Phoenix, Arizona
- A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaPHASE3 · Recruiting · Ivy Brain Tumor Center · Birmingham, Alabama